About Us

Expert Hands, Healing Healths

Colorectal Surgeon

About Ms. Annamaria Minicozzi

Dr. Minicozzi is a Clinical Reader in Colorectal Surgery at the Blizard Institute at Queen Mary University of London, and Consultant Colorectal and Peritoneal Surgeon at the Royal London Hospital – Barts Health NHS Trust. She is the lead for colorectal cancer surgery and the colorectal cancer multidisciplinary team (MDT). Additionally, she leads the Multidisciplinary Peritoneal Oncology service at Barts which she established in 2020. 

She completed her higher surgical training at the Verona University Hospital. Through her training, she successfully completed an International Colorectal Surgical Oncology Fellowship on Organ Preservation/Watch & Wait in rectal cancer (Sao Paolo, Brazil) and a second International Colorectal Fellowship in advanced and recurrent rectal cancer at the Karolinska Hospital (Stockholm, Sweden). In 2010, she was awarded a PhD for her work on multimodal imaging in colorectal cancer. In 2014, she became a Fellow of the Royal College of Surgeons of England.

Year of experience
0 +
Surgery done
0 +

Following the completion of her general surgery training, Dr. Minicozzi embarked on three Colorectal Surgery fellowships for highly specialist training in:

  1. Complex colorectal cancer surgery, inflammatory bowel disease surgery, polyposis and inherited cancers at St Marks Hospital. 
  2. Royal College of Surgeons Fellowship in complex inflammatory bowel disease and intestinal failure surgery at the Royal London Hospital. 
  3. Royal College of Surgeons Fellowship in advanced minimally invasive colorectal cancer surgery at Peterborough City Hospital.

Dr. Minicozzi’s specialist clinical and academic interests focus on colorectal cancer treatments that require innovative and advanced therapies due to their complexity. She has been responsible in establishing a CRS & HIPEC service for peritoneal metastases from colorectal and appendiceal cancer. Additionally, she has also conducted research on single cell sequencing in rectal cancer to support the Organ Preservation/Watch & Wait strategy in patients with rectal cancer who achieve a clinical complete response after neoadjuvant treatment. She is also the Principal Investigator (PI) of a national randomised trial investigating pressurised intraperitoneal aerosolised chemotherapy (PIPAC) for colorectal cancer patients with extensive peritoneal metastases that cannot be treated by conventional treatments.

Mission & Vision

Get The Best Treatment From The Most Experienced Colorectal Surgeon

Mission

At Dr. Minicozzi’s Clinic, our mission is to provide compassionate, patient-centered care using advanced medical expertise in gastroenterology. We are committed to diagnosing, treating, and preventing digestive disorders with cutting-edge treatments

Vision
Our vision is to be a leading center for gastrointestinal health, setting new standards in innovation, excellence, and patient care. We strive to empower individuals with knowledge and treatment solutions, improving digestive wellness and enhancing the quality of life for our patients

Ms. Annamaria Minicozzi Honored with Paul Harris Fellowship Award

Fellow Rotarian Ms. Annamaria Minicozzi, consultant colorectal surgeon at the Royal London Hospital, receives the Paul Harris Fellowship Award.

Her dedication to patients goes from thorough and continued care to the establishment of the very first HiPEC service in London, a legacy which will go well beyond her one to one full dedication to patients.

In line with the Rotarian mandate of service above self, she has been awarded the Paul Harris prize.

The award at the Barts Health Heroes Ceremony 2025 in London

Ms. Annamaria Minicozzi, a surgeon specialising in colorectal oncology, was officially awarded the title of “hero” at the Barts Health Heroes 2025 Awards in London.

An acknowledgement that came thanks to his important contribution to surgery and the care of oncology patients.

Dr Minicozzi is the lead of the colorectal cancer surgery service at the Royal London Hospital in London and the lead of the first centre in the British capital dedicated to ultra-specialised therapies – such as IntraPeritoneal and IntraThoracic Hyperthermic Chemotherapy – which guarantee new treatment options  for patients from London and North East of London.